Table 1.

List of macaques used in the study.

Macaque	Sex	Virus	Week p.i.	Plasma VL	Sample Type	cART Regiment	Days after cART start
IJ49	M	SIVmac251	16	8,100,000	PBMC	n/a	n/a
IB80	M	SIVmac251	16	11,000,000	PBMC	n/a	n/a
IN44	M	SIVmac251	9	910,000	PBMC	n/a	n/a
GL03	M	SIV∆Nef	16	65	PBMC	n/a	n/a
HT20	M	SIV∆Nef	9	15	PBMC	n/a	n/a
JN70	M	SIV∆Nef	14	7,000	PBMC	n/a	n/a
JN70-R	M	SIV∆Nef	18	30,000	PBMC	n/a	n/a
JN27	M	SIV∆Nef	16	29,000	PBMC	n/a	n/a
IC50	M	SIV∆Nef	15	5,400	PBMC	n/a	n/a
IH05	M	SIV∆Nef	20	65	PBMC	n/a	n/a
JI44	M	SIV∆Nef	14	350	PBMC	n/a	n/a
HE49	M	SIV∆Nef	9	2,300	PBMC	n/a	n/a
IM98	M	SIV∆Nef	15	1,000	PBMC	n/a	n/a
REt15R	F	SIVmac239Nef_Stop	6	6857	PBMC	PMPA/FTC/L-870812	4
RFw15R	F	SIVmac239Nef_Stop	6	127365	PBMC	PMPA/FTC/L-870812	4
RHd15R	F	SIVmac239Nef_Stop	6	11635	PBMC	PMPA/FTC/L-870812	4
RKc15R	F	SIVmac239Nef_Stop	6	40385	PBMC	PMPA/FTC/L-870812	4
RGe15R	F	SIVmac239Nef_Stop	6	489923	PBMC	PMPA/FTC/L-870812	4
Rld16R	F	SIVmac239Nef_Stop	6	132347	PBMC	PMPA/FTC/L-870812	4
RLm15R	F	SIVmac239Nef_Stop	6	13603	PBMC	PMPA/FTC/L-870812	4
RMb15R	F	SIVmac239Nef_Stop	6	13267	PBMC	PMPA/FTC/L-870812	4
RLz8	F	SIVmac239	32	< 1,000	PBMC	PMPA/FTC/RAL/DRV	63
Rwp8	F	SIVmac239	33	< 1,000	PBMC	PMPA/FTC/RAL/DRV	70
RMq8	F	SIVmac239	36	< 1,000	PBMC	PMPA/FTC/RAL/DRV	91
Rzp11	F	SIVmac239	35	< 50	LN	PMPA/FTC/RAL/DRV	84
Rlp10	F	SIVmac239	33	< 50	LN	PMPA/FTC/RAL/DRV	70
Rkt9	F	SIVmac239	33	< 50	LN	PMPA/FTC/RAL/DRV	70
Rfw8	F	SIVmac239	33	< 50	LN	PMPA/FTC/RAL/DRV	70

5 different groups of macaques were used to develop and validate the SIV TILDA assays. Groups differed by virus used for infection, absence or presence of cART treatment and pVL. Detailed characteristics of each animals are listed. Animals used for SHIV_AD8OE studies are listed in Table S1.